Skip to main content
Article thumbnail
Location of Repository

Acute effects of elevated NEFA on vascular function: a comparison of SFA and MUFA

By Katie Jane Newens, Abby Kerrin Thompson, Kim Geraldine Jackson, John Wright and Christine Mary Williams


There is emerging evidence to show that high levels of NEFA contribute to endothelial dysfunction and impaired insulin sensitivity. However,\ud the impact of NEFA composition remains unclear. A total of ten healthy men consumed test drinks containing 50 g of palm stearin\ud (rich in SFA) or high-oleic sunflower oil (rich in MUFA) on separate occasions; a third day included no fat as a control. The fats were emulsified\ud into chocolate drinks and given as a bolus (approximately 10 g fat) at baseline followed by smaller amounts (approximately 3 g fat)\ud every 30 min throughout the 6 h study day. An intravenous heparin infusion was initiated 2 h after the bolus, which resulted in a three- to\ud fourfold increase in circulating NEFA level from baseline. Mean arterial stiffness as measured by digital volume pulse was higher during the\ud consumption of SFA (P,0·001) but not MUFA (P¼0·089) compared with the control. Overall insulin and gastric inhibitory peptide\ud response was greater during the consumption of both fats compared with the control (P,0·001); there was a second insulin peak in\ud response to MUFA unlike SFA. Consumption of SFA resulted in higher levels of soluble intercellular adhesion molecule-1 (sI-CAM) at\ud 330 min than that of MUFA or control (P#0·048). There was no effect of the test drinks on glucose, total nitrite, plasminogen activator\ud inhibitor-1 or endothelin-1 concentrations. The present study indicates a potential negative impact of elevated NEFA derived from the consumption\ud of SFA on arterial stiffness and sI-CAM levels. More studies are needed to fully investigate the impact of NEFA composition on risk\ud factors for CVD

Publisher: Cambridge University Press
Year: 2011
OAI identifier:

Suggested articles


  1. (2003). Acute elevations of medium- and long-chain fatty acid have different impacts on endothelium-dependent vasodilation in humans.
  2. (2002). Acute haemodynamic effects of lipolysis-induced increase of free fatty acids in healthy men.
  3. (2002). Acute ingestion of a meal rich in n-3 polyunsaturated fatty acids results in rapid gastric emptying in humans.
  4. (2003). Adhesion molecules and atherosclerosis.
  5. (2009). Arterial stiffness in relation to subclinical atherosclerosis.
  6. (2007). Cardiovascular actions of insulin.
  7. (2010). Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review.
  8. (2009). Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells.
  9. (2009). Comparative effects of three popular diets on lipids, endothelial function, and C-reactive protein during weight maintenance.
  10. (2002). Dietary modification of inflammation with lipids.
  11. (2000). Differences in glucose-dependent insulinotrophic polypeptide hormone and hepatic lipase in subjects of southern and northern Europe: implications for postprandial lipemia.
  12. (1999). Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects.
  13. (2005). Dose– response effect of elevated plasma free fatty acid on insulin signaling.
  14. (2008). Effect of the dietary fat quality on insulin sensitivity.
  15. (2004). Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.
  16. (2004). Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans.
  17. (1997). Elevated circulating free fatty acid levels impair endotheliumdependent vasodilation.
  18. (2003). Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects.
  19. (2003). Endothelial vasodilatory function is related to the proportions of saturated fatty NEFA and vascular function 1349 Br iti sh Jo ur na l of N ut ri tio n acids and alpha-linolenic acid in young men, but not in women.
  20. (2001). Endotheliumdependent vasodilation is related to the fatty acid composition of serum lipids in healthy subjects.
  21. (2000). Enhanced peripheral vasodilation in humans after a fatty meal.
  22. (2008). Fasting triacylglycerol status, but not polyunsaturated/saturated fatty acid ratio, influences the postprandial response to a series of oral fat tolerance tests.
  23. (1997). Fatty acids augment endothelium-dependent dilation in hand veins by a cyclooxygenase-dependent mechanism.
  24. (2002). FFA-induced endothelial dysfunction can be corrected by vitamin C.
  25. (2005). Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet.
  26. (2004). Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy.
  27. (2006). Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase.
  28. (2003). Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.
  29. (2000). Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men.
  30. (2008). Impaired postprandial endothelial function depends on the type of fat consumed by healthy men.
  31. (2002). Interaction between specific fatty acids, GLP-1 and insulin secretion in humans.
  32. (2007). Meal fatty acids and postprandial vascular reactivity.
  33. (2010). Molecular mechanisms underlying nutrient detection by incretin-secreting cells.
  34. (2003). Novel experimental protocol to increase specific plasma nonesterified fatty acids in humans.
  35. (1996). Obesity/ insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
  36. (2007). Olive, soybean and palm oils intake have a similar acute detrimental effect over the endothelial function in healthy young subjects.
  37. (2003). Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC)
  38. (1998). Plasma glucagon-like peptide-1 (7–36) amide (GLP-1) response to liquid phase, solid phase, and meals of differing lipid composition.
  39. (2002). Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals.
  40. (2003). Postprandial hypertriglyceridemia-induced endothelial dysfunction in healthy subjects is independent of lipid oxidation.
  41. (1994). Postprandial lipoprotein lipase, insulin and gastric inhibitory polypeptide responses to test meals of different fatty acid composition: comparison of saturated, n-6 and n-3 polyunsaturated fatty acids.
  42. (1998). Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes independent of obesity.
  43. (2001). Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study.
  44. (2007). Systemic plasma levels of nitrite/nitrate (NOx) reflect brachial flow-mediated dilation responses in young men and women.
  45. (2003). The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects.
  46. (2000). The impairment in endothelial function induced by non-esterified fatty acids can be reversed by insulin.
  47. (2007). The importance of free fatty acids in the development of type 2 diabetes.
  48. (1997). The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study.
  49. (2002). The types of circulating fatty acids influence vascular reactivity.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.